Evolution of the Average Target: VTEX

Evolution of the Target Price: VTEX

Changes in Analyst Recommendations: VTEX

73f29c5a22ec1.LMbxthSgxC1mFlbdE4zUSb0azx3pcAinKRSfPS3JJIs.HaeohXyS9EICLgySY7rkH_ltnmedPj3rb3_MSl-fcdhHjobdX5mMfghhYg~f86738a06c9f88aa13549a945fe341c4
01-15 VTEX Shares Fall After UBS Downgrade MT
01-15 UBS Downgrades VTEX to Neutral From Buy, Adjusts Price Target to $4 From $8 MT
25-10-16 Goldman Sachs Initiates Coverage on VTEX With Buy Rating, $5.30 Price Target MT
25-09-17 VTEX Shares Rise After Jefferies Upgrade MT
25-09-17 Jefferies Upgrades VTEX to Buy From Hold, Price Target is $6.50 MT
25-08-08 JPMorgan Downgrades VTEX to Neutral From Overweight, Trims Price Target to $6 From $7.50 MT
25-08-07 VTEX Q2 revenue misses estimates RE
25-05-22 Jefferies Initiates VTEX at Hold With $7.30 Price Target MT
24-12-20 UBS Adjusts VTEX Price Target to $11 From $12.50, Maintains Buy Rating MT
24-12-06 Citigroup Initiates VTEX at Neutral With $6.70 Price Target MT
24-08-12 UBS Adjusts Price Target on VTEX to $12.50 From $12, Maintains Buy Rating MT
24-05-14 VTEX Shares Jump After Upgrade From J.P. Morgan MT
24-05-14 JPMorgan Upgrades VTEX to Overweight From Neutral, Price Target is $9 MT
24-03-25 UBS Adjusts VTEX Price Target to $12 From $8.50, Maintains Buy Rating MT
24-01-05 Morgan Stanley Upgrades VTEX to Overweight From Equalweight, Adjusts Price Target Price Target to $8 From $5.50 MT
23-11-20 UBS Adjusts VTEX Price Target to $8.50 From $7.50 Maintains Buy Rating MT
23-11-08 Piper Sandler Adjusts Price Target on VTEX to $7 From $6, Maintains Overweight Rating MT
23-08-23 UBS Upgrades VTEX to Buy From Neutral, Adjusts Price Target to $7.50 From $4.70 MT
23-08-09 Piper Sandler Adjusts Price Target on VTEX to $6 From $5, Maintains Overweight Rating MT
23-05-10 Itau BBA Upgrades VTEX to Outperform From Market Perform With $6 Price Target MT
23-03-09 DA Davidson Initiates VTEX at Buy With $5 Price Target MT
22-12-20 Piper Sandler Cuts Price Target on VTEX to $5 From $6, Reiterates Overweight Rating MT
22-12-19 Morgan Stanley Downgrades VTEX to Equalweight From Overweight, Adjusts Price Target to $5 From $7 MT
22-11-02 UBS Adjusts VTEX Price Target to $4.70 From $4.30, Maintains Neutral Rating MT
22-10-20 UBS Initiates VTEX at Neutral with $4.30 Price Target MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.63%
+7.08%
+12.54%
+24.68%
+36.26%
+24.94%
+18.68%
+13.23%
-0.47%
Average +16.84%
Weighted average by Cap. +14.52%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.810USD
Average target price
5.960USD
Spread / Average Target
+56.43%
High Price Target
12.00USD
Spread / Highest target
+214.96%
Low Price Target
4.100USD
Spread / Lowest Target
+7.61%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Goldman Sachs
Jefferies & Co.
JPMorgan Chase
Citigroup
Morgan Stanley
Piper Sandler
Itau BBA
DA Davidson
BofA Securities
KeyBanc Capital Markets
Credit Suisse
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
3.810USD
Average target price
5.960USD
Spread / Average Target
+56.43%

Quarterly revenue - Rate of surprise